The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

May 2022

Danyelza, Margenza and Saphnelo to require prior authorization for URMBT members with Blue Cross non-Medicare plans

For dates of service on or after June 30, 2022, the drugs listed below will require prior authorization for UAW Retiree Medical Benefits Trust members with Blue Cross Blue Shield of Michigan non-Medicare plans. They may also have site of care requirements, quantity limit requirements or both.

These requirements apply when the drugs are administered in an outpatient setting. Also, they don’t apply to the UAW Retiree Health Care Trust (group number 70605) or the UAW International Union (group number 71714).

The listed drugs are covered under the medical benefit. See the table for more information. (When a cell is blank, the drug doesn’t have that requirement.)

Requirements
Brand name Generic name HCPCS code Prior authorization Site of care Quantity limits
Danyelza™ naxitamab-gqgk J9348 AIM Specialty Health®
Margenza®

margetuximab-cmkb

J9353 AIM Specialty Health®  
Saphnelo™

anifrolumab-fnia

J0491 NovoLogix®

Submitting prior authorization requests

Here’s information on how to submit requests:
To submit requests to AIM, use one of the following methods:

To learn how to submit requests through NovoLogix:

  1. Go to our Blue Cross Medical Benefit Drugs page.
  2. Scroll to the Blue Cross commercial column.
  3. Review the information in the How to submit authorization requests electronically using NovoLogix section.

NovoLogix offers real-time status checks and immediate approvals for certain medications.

Notes:

  • Accredo manages prior authorization requests for additional medical benefit drugs for these members.
  • Authorization isn’t a guarantee of payment. As always, health care practitioners need to verify eligibility and benefits for our members.

For more information

For additional information on requirements related to drugs covered under the medical benefit for URMBT members with Blue Cross non-Medicare plans, see:

We’ll update the pertinent drug lists to reflect the information in this article prior to the effective date.

AIM Specialty Health is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to manage authorizations for select services. For more information, go to our ereferrals.bcbsm.com website.

**Blue Cross Blue Shield of Michigan don’t own or control this website.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2021 American Medical Association. All rights reserved.